Univar Solutions Secures Exclusive Distribution Rights for Ingredion Pharma Starches in North America

Event summary

  • Univar Solutions’ Ingredients + Specialties division has been appointed as the exclusive distributor of Ingredion Pharma Solutions’ portfolio in the United States and Canada.
  • The agreement grants Univar exclusive distribution rights for Ingredion’s pharmaceutical starches in the US and Canada, branded as UNI-PURE® F, FL, GA, and WG-220.
  • The partnership expands Univar’s pharmaceutical and nutraceutical ingredients portfolio, including functional excipients like binders, fillers, and superdisintegrants.
  • Aaron Lee, Univar’s Global Senior VP of Health & Nutrition, highlighted the deal’s potential to address formulation challenges and support customer growth.

The big picture

This agreement represents a strategic move for both Univar Solutions and Ingredion, allowing Univar to bolster its presence in the high-value pharmaceutical ingredients market and Ingredion to expand its reach through a well-established distribution network. The deal underscores the ongoing trend of ingredient suppliers leveraging distribution partnerships to navigate complex regulatory landscapes and reach a broader customer base within the pharmaceutical sector, a market valued at over $150 billion annually.

What we're watching

Market Penetration
The success of the partnership hinges on Univar’s ability to effectively integrate Ingredion’s product line and leverage its existing distribution network to gain market share in the competitive pharmaceutical excipients space.
Regulatory Scrutiny
Increased regulatory focus on pharmaceutical ingredient sourcing and quality could create challenges for both companies, requiring ongoing compliance efforts and potentially impacting distribution margins.
Competitive Response
Other ingredient distributors may attempt to undercut Univar’s exclusive position or forge alternative partnerships with Ingredion, potentially creating pricing pressure and impacting long-term profitability.

Related topics

Market Expansion Pharmaceuticals